Detalhe da pesquisa
1.
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay.
Oncotarget
; 15: 200-218, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484152
2.
Identification of a Novel NRG1 Fusion with Targeted Therapeutic Implications in Locally Advanced Pediatric Cholangiocarcinoma: A Case Report.
Case Rep Oncol
; 16(1): 249-255, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37092120
3.
Analytic validation of NeXT Dx™, a comprehensive genomic profiling assay.
Oncotarget
; 14: 789-806, 2023 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646774
4.
The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series.
Oncotarget
; 12(18): 1836-1847, 2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34504655
5.
Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra®.
Oncotarget
; 12(8): 726-739, 2021 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33889297
6.
Three-dimensional imaging and quantitative analysis in CLARITY processed breast cancer tissues.
Sci Rep
; 9(1): 5624, 2019 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30948791
7.
Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series.
Oncotarget
; 13: 1174, 2022 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36289011
8.
Analytical Validation of a Highly Quantitative, Sensitive, Accurate, and Reproducible Assay (HERmark) for the Measurement of HER2 Total Protein and HER2 Homodimers in FFPE Breast Cancer Tumor Specimens.
Patholog Res Int
; 2010: 814176, 2010 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21151530